Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.

We speak with the authors of two studies into extreme increases in US drug pricing, and attempts by lawmakers to bring the price-jackers into line.

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.